New Zealand markets open in 4 hours 24 minutes

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8150-0.1750 (-4.39%)
As of 01:35PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-70,738
-47,967
-147,559
-148,352
-99,254
Depreciation & amortisation
526
513
530
469
582
Stock-based compensation
15,701
14,510
20,589
22,319
18,770
Change in working capital
-2,143
-5,203
-5,307
-8,838
-4,076
Accounts receivable
1,256
-1,593
-5,406
-5,451
-237
Inventory
459
3,737
-12,708
-3,471
0
Accounts payable
-448
-3,372
4,421
-675
-244
Other working capital
-56,177
-38,337
-129,126
-132,108
-83,742
Other non-cash items
2,414
2,082
3,083
1,704
781
Net cash provided by operating activities
-56,177
-38,337
-128,620
-132,108
-83,742
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-506
-
-
Purchases of investments
-112,905
-124,690
-65,023
0
0
Sales/maturities of investments
103,000
127,500
15,000
0
0
Net cash used for investing activities
-9,905
2,810
-50,529
0
152
Cash flows from financing activities
Debt repayment
-
-26,688
0
0
-
Common stock issued
-
0
52,383
86,429
0
Other financing activities
-
-281
-43
-1,411
-620
Net cash used provided by (used for) financing activities
25,404
-26,912
52,495
145,863
21,688
Net change in cash
-40,678
-62,439
-126,654
13,755
-61,902
Cash at beginning of period
93,551
94,907
221,561
207,806
269,708
Cash at end of period
52,873
32,468
94,907
221,561
207,806
Free cash flow
Operating cash flow
-56,177
-38,337
-128,620
-132,108
-83,742
Capital expenditure
-
-
-506
-
-
Free cash flow
-56,177
-38,337
-129,126
-132,108
-83,742